STAT News Pharma
healthCenter
STAT+: Pharmalittle: We’re reading about a Huntington’s gene therapy, Novo’s challenges, and moretranslating…
UniQure has submitted its Huntington’s gene therapy to the FDA, investors remain unenthusiastic on Novo Nordisk, and more of the latest pharma headlines in today's Pharmalittle newsletter.
Keywords#Huntington’s#Pharmalittle#Novo’s#STAT#We’re
Comments
Sign in to join the discussion.
Loading comments…